Acetato de eslicarbazepina Pharmakern 800 mg Comprimido

מדינה: פורטוגל

שפה: פורטוגלית

מקור: INFARMED (Autoridade Nacional do Medicamento e Produtos de Saúde)

מרכיב פעיל:

Acetato de eslicarbazepina

זמין מ:

Pharmakern Portugal - Produtos Farmacêuticos, Sociedade Unipessoal, Lda.

קוד ATC:

N03AF04

INN (שם בינלאומי):

Acetate eslicarbazepina

כמות:

800 mg

טופס פרצבטיות:

Comprimido

הרכב:

Acetato de eslicarbazepina 800 mg

מסלול נתינה (של תרופות):

Via oral

יחידות באריזה:

Blister 20 unidade(s)

סיווג:

2.6 - Antiepilépticos e anticonvulsivantes

סוג מרשם:

MSRM

קבוצה תרפויטית:

Genérico

איזור תרפויטי:

eslicarbazepine

סממני תרפויטית:

Duração do Tratamento: Longa Duração

leaflet_short:

Número de Registo: 5788708 CNPEM: 50117254 CHNM: 10097542 Não Comercializado

מצב אישור:

Autorizado

תאריך אישור:

2020-01-15

עלון מידע

$3529$'2(0

,1)$50('


)ROKHWRLQIRUPDWLYR,QIRUPD©¥RSDUDRXWLOL]DGRU
$FHWDWRGH(VOLFDUED]HSLQD3KDUPDNHUQPJFRPSULPLGRV
$FHWDWRGHHVOLFDUED]HSLQD
/HLDFRPDWHQ©¥RWRGRHVWHIROKHWRDQWHVGHFRPH©DUDWRPDURXGDUHVWHPHGLFDPHQWR
¢VXDFULDQ©DSRLVFRQW«PLQIRUPD©¥RLPSRUWDQWHSDUDVL
&RQVHUYHHVWHIROKHWR3RGHWHUQHFHVVLGDGHGHROHUQRYDPHQWH
&DVRDLQGDWHQKDG¼YLGDVIDOHFRPRVHXP«GLFRRXIDUPDF¬XWLFR
(VWHPHGLFDPHQWRIRLUHFHLWDGRDSHQDVSDUDVL1¥RGHYHG£ORDRXWURV2
PHGLFDPHQWRSRGHVHUOKHVSUHMXGLFLDOPHVPRTXHDSUHVHQWHPRVPHVPRVVLQDLVGH
GRHQ©D
6HWLYHUTXDLVTXHUHIHLWRVLQGHVHM£YHLVLQFOXLQGRSRVV¯YHLVHIHLWRVLQGHVHM£YHLVQ¥R
LQGLFDGRVQHVWHIROKHWRIDOHFRPRVHXP«GLFRRXIDUPDF¬XWLFR

2TXHFRQW«PHVWHIROKHWR
2TXH«$FHWDWRGH(VOLFDUED]HSLQD3KDUPDNHUQHSDUDTXH«XWLOL]DGR
2TXHSUHFLVDGHVDEHUDQWHVGHWRPDU$FHWDWRGH(VOLFDUED]HSLQD3KDUPDNHUQ
&RPRWRPDU$FHWDWRGH(VOLFDUED]HSLQD3KDUPDNHUQ
(IHLWRVLQGHVHM£YHLVSRVV¯YHLV
&RPRFRQVHUYDU$FHWDWRGH(VOLFDUED]HSLQD3KDUPDNHUQ
&RQWH¼GRGDHPEDODJHPHRXWUDVLQIRUPD©·HV
$3529$'2(0

,1)$50('



2TXH«$FHWDWRGH(VOLFDUED]HSLQD3KDUPDNHUQHSDUDTXH«XWLOL]DGR
$FHWDWRGH(VOLFDUED]HSLQD3KDUPDNHUQFRQW«PDVXEVW¤QFLDDWLYDDFHWDWRGH
HVOLFDUED]HSLQD
$FHWDWRGH(VOLFDUED]HSLQD3KDUPDNHUQSHUWHQFHDXPJUXSRGHPHGLFDPHQWRV
FKDPDGRVDQWLHSLO«WLFRVH«XVDGRSDUDWUDWDUDHSLOHSVLDXPDGRHQ©DTXHVHPDQLIHVWD
SRUFRQYXOV·HVRXFULVHVHSLO«WLFDVUHSHWLGDV
$FHWDWRGH(VOLFDUED]HSLQD3KDUPDNHUQ«XVDGR
LVRODGDPHQWHPRQRWHUDSLDQRWUDWDPHQWRGHGRHQWHVDGXOWRVFRPHSLOHSVLD
UHFHQWHPHQWHGLDJQRVWLFDGD
HPFRQMXQWRFRPRXWURVPHGLFDPHQWRVDQWLHSLO«WLFRVWHUDS¬XWLFDDGMXYDQWHQR
WUDWDPHQWRGHGRHQWHVDGXOWRVDGROHVFHQWHVHFULDQ©DVFRPPDLVGHDQRVW¬PFULVHV
TXHDIHWDPXPDSDUWHGRF«UHEURFULVHVSDUFLDLV(VWDVFULVHVSRGHPVHUVHJXLGDVRX
Q¥RGHXPDFULVHTXHDIHWDWRGRR

מאפייני מוצר

$3529$'2(0

,1)$50('


5(6802'$6&$5$&7(567,&$6'20(',&$0(172
120('20(',&$0(172
$FHWDWRGH(VOLFDUED]HSLQD3KDUPDNHUQPJFRPSULPLGRV
&20326,‰…248$/,7$7,9$(48$17,7$7,9$
&DGDFRPSULPLGRFRQW«PPJGHDFHWDWRGHHVOLFDUED]HSLQD
([FLSLHQWHFRPHIHLWRFRQKHFLGR
6µGLRVREDIRUPDGHFURVFDUPHORVHVµGLFDPJSRUFRPSULPLGR
/LVWDFRPSOHWDGHH[FLSLHQWHVYHUVHF©¥R
)250$)$50$&Œ87,&$
&RPSULPLGR
&RPSULPLGRVEUDQFRVREORQJRVELFRQYH[RVHFRPXPDUDQKXUDHPDPERVRVODGRV
FRPFRPSULPHQWRGHPP2FRPSULPLGRSRGHVHUGLYLGLGRHPGRVHVLJXDLV
,1)250$‰—(6&/1,&$6
,QGLFD©·HVWHUDS¬XWLFDV
$FHWDWRGH(VOLFDUED]HSLQD3KDUPDNHUQ«LQGLFDGR
FRPRPRQRWHUDSLDQRWUDWDPHQWRGHFULVHVHSLO«WLFDVSDUFLDLVFRPRXVHP
JHQHUDOL]D©¥RVHFXQG£ULDHPGRHQWHVDGXOWRVFRPHSLOHSVLDUHFHQWHPHQWH
GLDJQRVWLFDGD
FRPRWHUDS¬XWLFDDGMXYDQWHHPGRHQWHVDGXOWRVDGROHVFHQWHVHFULDQ©DVFRPPDLVGH
DQRVGHLGDGHFRPFULVHVHSLO«WLFDVSDUFLDLVFRPRXVHPJHQHUDOL]D©¥RVHFXQG£ULD
$3529$'2(0

,1)$50('


3RVRORJLDHPRGRGHDGPLQLVWUD©¥R
3RVRORJLD
$GXOWRV
$FHWDWRGH(VOLFDUED]HSLQD3KDUPDNHUQSRGHVHUWRPDGRFRPRPRQRWHUDSLDRXVHU
DGLFLRQDGRDXPDWHUDS¬XWLFDDQWLFRQYXOVLYDQWHH[LVWHQWH$GRVHLQLFLDOUHFRPHQGDGD«
GHPJXPDYH]SRUGLDTXHGHYHVHUDXPHQWDGDSDUD
PJXPDYH]SRUGLDDSµVXPDRXGXDVVHPDQDV'HSHQGHQGRGDUHVSRVWD
LQGLYLGXDOGHFDGDGRHQWHHVWDGRVHSRGHVHUDXPHQWDGDSDUDPJXPDYH]SRU
GLD$OJXQVGRHQWHVHPUHJLPHGHPRQRWHUDSLDSRGHU¥REHQHILFLDUGHXPDGRVHGH
PJXPDYH]SRUGLDYHUVHF©¥R
3RSXOD©·HVHVSHFLDLV
,GRVRVFRPPDLVGHDQRVGHLGDGH
1¥R«QHFHVV£ULRDMXVWHGHGRVHQDSRSXOD©¥RLGRVDGHVGHTXHDIXQ©¥RUHQDOQ¥R
HVWHMDFRPSURPHWLGD'HYLGR¢H[LVW¬QFLDGHGDGRVPXLWROLPLWDGRVVREUHRUHJLPHGH
PRQRWHUDSLDFRPPJHPLGRVRVHVWDGRVHQ¥RHVW£UHFRPHQGDGDSDUDHVWD
SRSXOD©¥R
&RPSURPLVVRUHQDO
5HFR